Results 11 to 20 of about 810,489 (200)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon

International Journal of Microbiology, 2023
Carbapenem-resistant Enterobacterales (CRE) pathogens have been increasingly isolated and reported in Lebanon. Several studies have been published over the last two decades about the CRE situation in the country.
Mahdi Fadlallah, Elie Salem-Sokhn, Ahmad Salman   +2 more
core   +5 more sources

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019 [PDF]

Antimicrobial Resistance & Infection Control, 2022
Background: The Netherlands is currently considered a low endemic country for carbapenem-resistant Enterobacterales (CRE) and carbapenemase-producing Enterobacterales (CPE), experiencing only sporadic hospital outbreaks.
Schouls, L.M., Woudt, S.H.S., Notermans, D.W., Greeff, S.C. de, Infect Dis Surveillance Informatio, Schoffelen, A.F., Dutch CPE Surveillance Study Grp, Wielders, C.C.H., Kuijper, E.J., Bakker, J., Hendrickx, A.P.A.   +10 more
core   +15 more sources

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales

Antibiotics, 2023
Metallo-beta-lactamases (MBLs) are enzymes that break down carbapenem antibiotics, leading to carbapenem-resistant organisms. Carbapenemase-resistant Enterobacterales (CRE) is one of them. Outbreaks of CRE infection can occur in healthcare facilities and
Kentarou Takei, Hajime Kanamori, Asami Nakayama, Mikiko Chiba, Yumiko Takei, Issei Seike, Chiho Kitamura, Hiroaki Baba, Kengo Oshima, Koichi Tokuda   +9 more
doaj   +2 more sources

Phenotypic detection of carbapenem-resistant Enterobacterales in clinical isolates at a tertiary care hospital

Journal of Current Research in Scientific Medicine
Background: In the past decade, there has been a global emergence of carbapenem-resistant Gram-negative bacilli, especially Enterobacterales. Carbapenem resistance is attributed to the ability of the bacteria to produce carbapenemases.
Astha Sinha, Mamta Gour, Riti Jain Seth
doaj   +2 more sources

Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria

Cells
We investigated the activity of cefiderocol/β-lactamase inhibitor combinations against clinical strains with different susceptibility profiles to cefiderocol to explore the potentiality of antibiotic combinations as a strategy to contain the major public
Russell E. Lewis, Marta Palombo, Erica Diani, Benedetta Secci, Davide Gibellini, Paolo Gaibani   +5 more
doaj   +2 more sources

Carbapenem-resistant Enterobacterales in solid organ transplant recipients

American Journal of Transplantation
Carbapenem-resistant Enterobacterales (CRE) are an important threat to the health of solid organ transplant recipients (SOTr); data comparing outcomes of SOTr with CRE to non-SOTr with CRE are lacking.
Patel, Gopi, Chen, Liang, Cober, Eric, Hill, Carol, van Duin, David, Grant, Matthew, Boutzoukas, Angelique E, Dai, Weixiao, Satlin, Michael J, Abbo, Lilian M, Bonomo, Robert A, McCarty, Todd P, Arias, Cesar A, Komarow, Lauren, Fries, Bettina C   +14 more
core   +4 more sources

Organism-specific Trends in Carbapenem-resistant Enterobacterales Infections in a Cohort of Hospitalized Patients, 2012–2022

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Carbapenem-resistant Enterobacterales (CRE) infections are an urgent public health threat. An estimated 12,700 CRE (including E. coli, Klebsiella spp., and Enterobacter spp.) infections occurred in the United States in 2020.
Mohammed Khan, Hannah Wolford, Natalie McCarthy, Babatunde Olubajo, Jonathan Bishop, James Baggs, Joseph Lutgring, Sujan Reddy, Maroya Walters   +8 more
doaj   +2 more sources

Cefiderocol Susceptibility and Carbapenemase Profiles in Carbapenem-Resistant Enterobacterales. [PDF]

Infect Dis Clin Microbiol
Objective: Cefiderocol is a siderophore cephalosporin used as a last resort treatment for infections caused by carbapenem-resistant Enterobacterales (CRE), which pose a threat to public health. This study aimed to determine cefiderocol susceptibility among CRE isolates from the Western Marmara Region of Türkiye and to evaluate the association between ...
Bayrak A, Akçalı A, Mutlu R, Çakıcı N.   +3 more
europepmc   +5 more sources

Carbapenem-resistant Acinetobacter baumannii and Carbapenem-resistant Enterobacterales in US Dialysis Populations, 2016-2021

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Infections lead to high mortality among patients on chronic dialysis; knowledge of multi-drug resistant infections is limited. The Centers for Disease Control and Prevention’s Emerging Infections Program (EIP) conducts laboratory- and ...
Nadezhda Duffy, Christopher Czaja, Jesse Jacob, Shannon Novosad, Alice Guh, Danica Gomes, P. Maureen Cassidy, Sandra Bulens, Joshua Brandenburg, Gillian Smith, Elisabeth Vaeth, Joelle Nadle, Christopher Wilson, Julian Grass, Nicole Stabach, Kristina Flores, Helen Johnston, Ghinwa Dumyati, Sean O’Malley, Rebecca Pierce, Paula Snippes Vagnone, Ruth Lynfield, Daniel Muleta   +22 more
core   +3 more sources

Activity of mecillinam against carbapenem-resistant Enterobacterales

Journal of Antimicrobial Chemotherapy, 2022
Abstract Background Despite the fact that carbapenem-resistant Enterobacterales (CRE) mostly cause urinary tract infections (UTIs), only few studies have focused on the efficacity of mecillinam against these CRE.
Emeraud, Cécile, Godmer, Alexandre, Girlich, Delphine, Vanparis, Océane, Mahamdi, Fériel, Creton, Elodie, Jousset, Agnès, Naas, Thierry, Bonnin, Rémy, Dortet, Laurent   +9 more
openaire   +3 more sources